While the reason for the review is unclear, a source speculated that Abbott could be seeking to consolidate its media accounts into one partnership. The company is understood to work with a variety of agencies across the region, including ZenithOptimedia in China and MEC in Pakistan. Abbott has operations in 13 other markets in Asia-Pacific.
Meanwhile, three holding companies are believed to be in the fray for rival pharma giant Pfizer’s marketing communications business in Australia, which is believed to be the test market for a global review for its marketing activities. It is believed that Omnicom, Interpublic Group and WPP are involved in the pitch.
“They are looking at total communications and either total or partial consolidation, depending on the market,” said a source.
